RecallGuide.ca
    Health productsUpdated Jan 3, 2026Apo-MetoprololOfficial source

    Apo-Metoprolol recall in Canada: May contain oversized tablets

    Share:

    In plain language

    This recall involves Apo-Metoprolol 25 mg tablets sold in Canada. It's being recalled because an affected lot may contain oversized tablets. Consult your healthcare provider before stopping use and follow the steps in the official notice.

    What to do

    • Verify if your product is from lot TW5079.
    • Consult your healthcare provider before discontinuing use.
    • Contact Apotex Inc. if you have questions.
    • Report any health product related side effects to Health Canada.

    Get alerts for recalls like this

    Get email alerts when new recalls affect products in this category.

    Categories (optional)

    No spam. Unsubscribe anytime. We only email when there's a relevant recall.

    Affected products

    • Apo-Metoprolol (Metoprolol Tartrate Tablets USP) 25 mg

      Lot: TW5079

    Why this matters

    Product quality issue (oversized tablets)

    Do I have this product?

    This recall only applies to specific products. Follow the steps below to check.

    1. 1

      Check the product name

      Make sure your product name matches one of the affected products listed above.

    2. 2

      Check the lot number

      Lot numbers identify specific production batches.

      Affected lots: TW5079

    If your product matches one or more of the details above, it may be affected by this recall.

    If your product does not match these details, it is not affected by this recall.

    When in doubt, always check the official notice.

    Want alerts if similar products are recalled in Canada?

    Frequently Asked Questions

    Why was this product recalled?

    Product quality issue (oversized tablets)

    What should consumers do?

    Verify if your product is from lot TW5079. Consult your healthcare provider before discontinuing use. Contact Apotex Inc. if you have questions. Report any health product related side effects to Health Canada.

    Where was the product sold?

    This product was sold in Canada. For specific retailers or distribution areas, please check the official recall notice linked on this page.

    Is there a health risk?

    Yes, there may be a health risk. Product quality issue (oversized tablets)

    When was this product recalled?

    This product was recalled on December 12, 2023.

    Is the Apo-Metoprolol brand affected by this recall?

    Yes, Apo-Metoprolol products are affected by this recall. This recall involves Apo-Metoprolol 25 mg tablets sold in Canada. It's being recalled because an affected lot may contain oversized tablets. Consult your healthcare provider before stopping use and follow the steps in the official notice.